JPH01242563A - Production of organic plate crystal - Google Patents

Production of organic plate crystal

Info

Publication number
JPH01242563A
JPH01242563A JP6796788A JP6796788A JPH01242563A JP H01242563 A JPH01242563 A JP H01242563A JP 6796788 A JP6796788 A JP 6796788A JP 6796788 A JP6796788 A JP 6796788A JP H01242563 A JPH01242563 A JP H01242563A
Authority
JP
Japan
Prior art keywords
long
amino acid
crystals
acid
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6796788A
Other languages
Japanese (ja)
Other versions
JPH0325413B2 (en
Inventor
Koichiro Sagawa
幸一郎 佐川
Takeshi Miyoshi
三芳 毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP6796788A priority Critical patent/JPH01242563A/en
Publication of JPH01242563A publication Critical patent/JPH01242563A/en
Publication of JPH0325413B2 publication Critical patent/JPH0325413B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To obtain an organic plate crystal useful as a cosmetic powder, solid lubricant, etc., by dissolving an amino acid derivative such as N-long-chain monoacyl basic amino acid in a strongly acidic or strongly alkaline aqueous solution, neutralizing the solution and crystallizing the compound. CONSTITUTION:A amino acid derivative of formula I-III (R1 and R2 are 7-21 alkyl; R3 is 8-20 alkyl; m and n are 1-4) is dissolved in an aqueous solvent having a pH of <=2 or >=11, the solution is neutralized and the compound is crystallized to obtain an organic plate crystal. The aqueous solvent is preferably contains 5-95vol.% (preferably 30-70vol.%) of a hydrophilic organic solvent such as alcohols, polyhydric alcohols or lower ketones and the pH is adjusted with hydrochloric acid, sulfuric acid, phosphoric acid, NaOH, etc. Crystals having uniform size can be produced by the above method to improve the decoloration and purification efficiency and suppress the foaming. Accordingly the yield of crystal per unit volume of crystallizer can be increased.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、下記−軟式(1)〜(3)で表される疎水性
のα−アミノ酸誘導体を用いた有機板状晶の工業的製造
法に関し、その目的とするところは化粧用粉体あるいは
固体潤滑剤等として好適な滑沢性に優れた有機板状晶を
得ることにある。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to an industrial method for producing organic platelet crystals using hydrophobic α-amino acid derivatives represented by the following soft formulas (1) to (3). The purpose is to obtain organic plate crystals with excellent lubricity suitable as cosmetic powders or solid lubricants.

RICONH(CH2)mcHcOOH(1)H2 R2NHCO(CH2)ncHcOOH(2>H2 R3CHCOOH(3) H2 (ただし、R1およびR2は炭素数7〜21の長鎖アル
キル基を、R3は炭素数8〜20の長鎖アルキル基を表
す、また、mおよびnは1〜4の整数を表す、) 従来の技術と問題点 N−長鎖モノアシル塩基性アミノ酸、酸性アミノ酸−ω
−長鎖アミド、α−アミノ長鎖脂肪酸などのアミノ酸誘
導体は水や通常の有機溶剤に極めて溶けにくく、かつ、
はっ水性、抗酸化性、滑沢性などの特長をもつため、有
機系の新しい粉体素材として化粧品、潤滑剤などの分野
への展開が検討されている(特開昭61−10503 
)、  かかる分野で用いられる粉体素材では、粒子の
形状もその物性に大きく影響するため、用途に適した結
晶形や粒度のものを工業的規模で製造することが必要と
なる。しかしながら、上述したようにこれらのアミノ酸
誘導体はいずれも水や通常の有1f!!溶剤に極めて溶
けにくく、そのため再結晶による精製や粒形調整には数
々の問題が生じる0例えば、少量のN−アシル塩基性ア
ミノ酸を多量のアルカリ性あるいは酸性水溶液に溶解し
た後、中和することによって結晶を得る方法は公知(特
公昭51−28610、油化学、26.2.26 (1
977))であるが、溶解性が低いため中和時に急激な
晶析が起こり、結晶形の制御が難しく、均一な粒度の結
晶を得ることはできない、また、水溶液からの晶析だけ
では着色性の有機物、例えばアミノカプロラクタムやア
ルキルアミンなどの除去が充分できず、結晶が茶褐色と
なるなどの問題が生じる。さらに、溶解時に著しい発泡
が起こるため、晶析槽の容量に対する液量が少なくなり
コスト面でも工業的生産には不適当である。
RICONH(CH2)mcHcOOH(1)H2 R2NHCO(CH2)ncHcOOH(2>H2 R3CHCOOH(3) H2 (However, R1 and R2 are long chain alkyl groups with 7 to 21 carbon atoms, and R3 is a long chain alkyl group with 8 to 20 carbon atoms. Represents a long chain alkyl group, and m and n represent integers from 1 to 4.) Prior art and problems N - long chain monoacyl basic amino acid, acidic amino acid - ω
- Amino acid derivatives such as long-chain amides and α-amino long-chain fatty acids are extremely insoluble in water and ordinary organic solvents, and
Because it has characteristics such as water repellency, antioxidation, and smoothness, it is being considered for use in cosmetics, lubricants, and other fields as a new organic powder material (Japanese Patent Application Laid-Open No. 10503-1983).
), Since the particle shape of powder materials used in such fields has a large effect on their physical properties, it is necessary to manufacture them on an industrial scale with crystal shapes and particle sizes suitable for the application. However, as mentioned above, these amino acid derivatives all contain water and the usual 1f! ! It is extremely difficult to dissolve in solvents, which causes many problems in purification by recrystallization and grain shape adjustment. For example, by dissolving a small amount of N-acyl basic amino acid in a large amount of alkaline or acidic aqueous solution and then neutralizing it. The method for obtaining crystals is known (Japanese Patent Publication No. 51-28610, Yukagaku, 26.2.26 (1)
977)), but due to its low solubility, rapid crystallization occurs during neutralization, making it difficult to control the crystal shape and making it impossible to obtain crystals with uniform particle size.Furthermore, crystallization from an aqueous solution alone does not cause coloration. However, organic substances such as aminocaprolactam and alkylamines cannot be removed sufficiently, resulting in problems such as crystals turning brown. Furthermore, since significant foaming occurs during dissolution, the amount of liquid is small relative to the capacity of the crystallization tank, making it unsuitable for industrial production in terms of cost.

一方、熱酢酸に溶解後冷却し再結晶する方法もあるが、
これらのアミノ酸誘導体は90’Cの熱酢酸にも高々数
%しか溶解せず、しかも酢酸は回収に高温を要するなど
、やはり工業的再結晶法としては不適当である。また、
N−長鎖モノアシル塩基性アミノ酸を過酸化水素水等を
用いて洗浄し精製する方法も考案されているが(特公昭
57−47984)、かかる方法は単に不純物を淘汰し
、脱色精製に効果を発揮するだけであり、その結晶形や
粒度を調整することはできない。
On the other hand, there is a method of dissolving in hot acetic acid and then cooling and recrystallizing.
These amino acid derivatives are only a few percent soluble at most in hot acetic acid at 90'C, and acetic acid requires high temperatures for recovery, making it unsuitable for industrial recrystallization. Also,
A method has also been devised in which N-long chain monoacyl basic amino acids are washed and purified using hydrogen peroxide, etc. (Japanese Patent Publication No. 57-47984), but such a method simply removes impurities and is not effective in decolorizing and purifying. The crystal shape and grain size cannot be adjusted.

発明が解決しようとする課題 上述したように、N−長鎖モノアシル塩基性アミノ酸、
酸性アミノ酸−ω−長鎖アミド、α−アミノ長鎖脂#酸
などのアミノ酸誘導体は、再結晶による精製自体が困難
な化合物であり、したがって、化粧品や固体潤滑剤等と
して用いるのに適した均一な粒度の純度の高い板状晶を
得る工業的に実施可能な方法は、これまで全く見いださ
れていないのが実状である。
Problems to be Solved by the Invention As mentioned above, N-long chain monoacyl basic amino acids,
Amino acid derivatives such as acidic amino acid-ω-long-chain amides and α-amino long-chain fatty acids are compounds that are difficult to purify by recrystallization, and therefore are suitable for use in cosmetics, solid lubricants, etc. The reality is that no industrially viable method for obtaining highly pure plate crystals with a certain particle size has been found so far.

課題を解決するための手段 本発明者らは、N−長鎖モノアシル塩基性アミノ酸、酸
性アミノ酸−ω−長鎖アミド、α−アミノ長鎖脂肪酸な
どのアミノ酸誘導体の晶析方法について種々検討した結
果、親水性の有機溶媒を含有するp H2以下またはp
)Ii 1以上の水性溶媒にこれらアミノ酸誘導体を溶
解させた後中和することにより、工業的にも有利に均一
な粒度の板状晶が得られることを見いだし本発明を完成
した。
Means for Solving the Problems The present inventors have conducted various studies on methods for crystallizing amino acid derivatives such as N-long-chain monoacyl basic amino acids, acidic amino acid-ω-long-chain amides, and α-amino long-chain fatty acids. , containing a hydrophilic organic solvent, pH below 2 or p
) Ii The inventors have completed the present invention by discovering that plate crystals with uniform particle size can be obtained industrially advantageously by dissolving these amino acid derivatives in one or more aqueous solvents and then neutralizing them.

本発明で用いられる親水性有v1溶媒としてはメタノー
ル、エタノール、プロパツール、ブタノール等の低級ア
ルコール類、エチレングリコール、グリセリン、1.3
ブチレングリコール等の多価アルコール類、アセトン、
メチルエチルケトン等の低級ケトン類等が挙げられ、特
にメタノールやインプロパツール等の低級アルコールが
有効である。
Hydrophilic V1 solvents used in the present invention include lower alcohols such as methanol, ethanol, propatool, butanol, ethylene glycol, glycerin, etc.
Polyhydric alcohols such as butylene glycol, acetone,
Examples include lower ketones such as methyl ethyl ketone, and lower alcohols such as methanol and impropatol are particularly effective.

これら親水性の有機溶媒は、はり水性が高く水に濡れに
くいアミノ酸誘導体の水性溶媒への分散性を高め、かつ
溶解時の発泡を抑制する作用がある。水性溶媒における
これら親水性有機溶媒の含有量は、5〜95vo1.%
、好ましくは30〜70vo1.%である。親水性有機
溶媒の含有量が低いと、アミノ酸誘導体の分散性や溶解
性が低下するため、中和時に急激な晶析が起こり均一な
粒径のものが得にくくなるという不利益が生じる。また
、脂肪酸、アルキルアミン等の原料やアミノカプロラク
タム等の副生不純物などの溶解度も低下するため、再結
晶による着色物質の精製効率も低下する。さらには発泡
抑制効果が低下するなどの不利益が生じる。一方、親水
性有機溶媒の含有量が高くなると、中和時に副生ずる無
機塩が析出し、アミノ酸誘導体の結晶に混入したり、あ
るいは原料アミノ酸の溶解度が低下するため、精製効率
はやはり低下する。
These hydrophilic organic solvents have the effect of increasing the dispersibility of amino acid derivatives that are highly hydrophilic and difficult to wet with water in aqueous solvents, and suppressing foaming during dissolution. The content of these hydrophilic organic solvents in the aqueous solvent is 5 to 95 vol. %
, preferably 30 to 70 vol. %. If the content of the hydrophilic organic solvent is low, the dispersibility and solubility of the amino acid derivative will decrease, resulting in the disadvantage that rapid crystallization occurs during neutralization, making it difficult to obtain particles of uniform particle size. Furthermore, the solubility of raw materials such as fatty acids and alkyl amines and by-product impurities such as aminocaprolactam is also reduced, and the efficiency of purification of colored substances by recrystallization is also reduced. Furthermore, there are disadvantages such as a decrease in the foaming suppressing effect. On the other hand, if the content of the hydrophilic organic solvent increases, the inorganic salts produced as a by-product during neutralization will precipitate and mix with the crystals of the amino acid derivative, or the solubility of the raw amino acid will decrease, resulting in a decrease in purification efficiency.

ここでアミノ酸誘導体を溶解する水性溶媒は、pH2以
下またはpH11以上、好ましくはp H1以下または
pH12以上の強酸性あるいは強アルカリ性にpH調整
されたものが用いられる。これはアミノ酸誘導体の溶解
性を高める上で必須の操作であり、概ねpH3〜PHI
OまでのpH領域、具体的にはアミノ酸誘導体のpKa
〜pKbのpH領域では、かかるアミノ酸誘導体は分子
内塩を形成しているため水性溶媒への溶解度は著しく低
く工業的に有利に精製再結晶することはできない。
The aqueous solvent in which the amino acid derivative is dissolved is adjusted to have a pH of 2 or less or 11 or more, preferably a strongly acidic or alkaline pH of 1 or less or 12 or more. This is an essential operation to increase the solubility of amino acid derivatives, and is generally performed at pH 3 to PHI.
pH range up to O, specifically pKa of amino acid derivatives
In the pH range of ~ pKb, such amino acid derivatives form inner salts, so their solubility in aqueous solvents is extremely low, and they cannot be industrially advantageously purified and recrystallized.

゛pH調整に用いる酸としては塩酸、硫酸、りん酸、硝
酸、バラトルエンスルフォン酸などのほか上記pH領域
に水性溶媒を調整できるものであれば如何なるものであ
ってもよく、また、アルカリについても・水酸化ナトリ
ウム、水酸化カリウムなどのほか、上記pH領域に水性
溶媒を調整できるものであれば任意のアルカリを用いる
ことができる。
゛As for the acid used for pH adjustment, in addition to hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, balatoluenesulfonic acid, etc., any acid that can adjust the aqueous solvent to the above pH range may be used. - In addition to sodium hydroxide, potassium hydroxide, etc., any alkali can be used as long as the aqueous solvent can be adjusted to the above pH range.

本発明の方法により有機板状晶を得るにあたって、その
晶析時の温度および中和時の酸あるいはアルカリの滴下
速度などは、アミノ酸誘導体の種類やその炭化水素鎖の
長さ、親水性有機溶媒の含有量、または目的とする結晶
の粒度などにより異なる0例えば10〜20μm程度の
粒度のα−アミノバルミチン酸の板状晶を、pH12以
上の50vo1%含水メタノール溶液から得る場合、 
晶析時の温度は40〜60℃が好ましく、かつ酸性溶液
の滴下は1時間〜2時間かけてゆっくり行うことが必要
となる。より低温で晶析したりあるいは滴下速度を早め
ると、結晶熟成が不十分となり粒度は小さくなる。また
、逆により高温でゆっくり中和しながら晶析させると結
晶の成長は進み大きな結晶が得られる。このように、粒
度はこれらの条件によって変るが、いずれの場合もその
形状は板状であり、かかる条件は本発明でいうところの
アミノ酸誘導体の板状晶を得るための必須の条件ではな
い、すなわち、晶析温度や滴下時間などの条件は、対象
とするアミノ酸誘導体の種類、目的とする粒度などに合
わせ、適宜設定すればよい。
In obtaining organic platelet crystals by the method of the present invention, the temperature during crystallization and the dropping rate of acid or alkali during neutralization are determined depending on the type of amino acid derivative, the length of its hydrocarbon chain, and the hydrophilic organic solvent. When obtaining α-aminobalmitic acid platelet crystals with a particle size of about 10 to 20 μm, which varies depending on the content of 0 or the particle size of the target crystal, for example, from a 50 vol 1% aqueous methanol solution with a pH of 12 or higher,
The temperature during crystallization is preferably 40 to 60°C, and the acidic solution must be added slowly over 1 to 2 hours. When crystallizing at a lower temperature or increasing the dropping rate, crystal ripening becomes insufficient and the particle size becomes smaller. On the other hand, if crystallization is carried out at high temperature while slowly neutralizing, crystal growth will proceed and large crystals will be obtained. As described above, the particle size changes depending on these conditions, but in any case, the shape is plate-like, and such conditions are not essential conditions for obtaining plate-like crystals of amino acid derivatives as defined in the present invention. That is, conditions such as crystallization temperature and dropping time may be appropriately set according to the type of amino acid derivative of interest, the intended particle size, and the like.

尚、本発明でいうところのアミノ酸誘導体を例示するな
らば、以下のものが挙られる。すなわち、特許請求の範
囲第一項記載の一般式(1)で示されるN−長鎖アシル
塩基性アミノ酸を構成する塩基性アミノ酸としては、α
、β−ジアミノプロピオン酸、α、γ−ジアミノ酪酸、
オルニチン、リジンなどが挙げられ、また、もう一方の
構成成分である脂肪酸としては、オクタン酸、デカン酸
、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリ
ン酸、イコサン酸、 トコサン酸、イソステアリン酸な
どが挙げられる。
Incidentally, the amino acid derivatives referred to in the present invention are exemplified by the following. That is, as the basic amino acid constituting the N-long chain acyl basic amino acid represented by the general formula (1) described in claim 1, α
, β-diaminopropionic acid, α, γ-diaminobutyric acid,
Ornithine, lysine, etc. are mentioned, and fatty acids that are the other component include octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, icosanoic acid, tocosanoic acid, isostearic acid, etc. It will be done.

、また、前記−最大(2)で示される酸性アミノ酸−ω
−長鎖アミドを構成する酸性アミノ酸としては、アスパ
ラギン酸、グルタミン酸、α−アミノアジピン酸、α−
アミノピメリン酸などが挙げられ、また、脂肪族アミン
としては、オクチルアミン、デシルアミン、ラウリルア
ミン、ミリスチルアミン、パルミチルアミン、ステアリ
ルアミン、イコシルアミン、トコジルアミンなどが挙げ
られる。
, and the acidic amino acid represented by maximum (2) above -ω
- Acidic amino acids constituting the long chain amide include aspartic acid, glutamic acid, α-aminoadipic acid, α-
Examples of the aliphatic amine include octylamine, decylamine, laurylamine, myristylamine, palmitylamine, stearylamine, icosylamine, and tocodylamine.

また、前記−最大(3)で示されるα−アミン長鎖脂肪
酸としては、α−アミンオクタン酸、α−アミノデカン
酸、α−アミノラウリン酸、α−アミノミリスチン酸、
α−アミノパルミチン酸、α−アミンステアリン酸、α
−アミノイコサン酸、α−アミノトコサン酸、α−アミ
ノイソステアリン酸などが挙げられる。
In addition, the α-amine long chain fatty acids represented by maximum (3) above include α-amine octanoic acid, α-aminodecanoic acid, α-aminolauric acid, α-aminomyristic acid,
α-aminopalmitic acid, α-amine stearic acid, α
-aminoicosanoic acid, α-aminotocosanoic acid, α-aminoisostearic acid, and the like.

本発明に於ける有機板状晶の製造法では、これらのアミ
ノ酸誘導体は、それぞれ光学活性体でもラセミ体でもよ
い。
In the method for producing organic platelets according to the present invention, each of these amino acid derivatives may be an optically active form or a racemic form.

実施例 以下に本発明の実施例を示すが、本発明がこれに限定さ
れるものでないことは勿論である。
EXAMPLES Examples of the present invention are shown below, but it goes without saying that the present invention is not limited thereto.

実施例I N−ラウロイルリジンの粗結晶10gをメタノールと1
0%水酸化すl−リウム水溶液の2:1混合溶液60c
c (pH12以上)に加え、40°Cに加温しなから
攪はん溶解する。温度を一定に保ちながら、10%塩酸
水溶液をゆっくり滴下し、pH6,5まで中和する。析
出した結晶をろ過、乾燥し白色板状結晶9.6gを得た
Example I 10 g of crude crystals of N-lauroyl lysine were mixed with methanol and 1
2:1 mixed solution of 0% sulfur hydroxide aqueous solution 60c
c (pH 12 or higher) and stir to dissolve while heating to 40°C. While keeping the temperature constant, slowly drop a 10% aqueous hydrochloric acid solution to neutralize to pH 6.5. The precipitated crystals were filtered and dried to obtain 9.6 g of white plate-like crystals.

実施例2 N−ラウロイルリジンの粗結晶10gをメタノールと1
0%塩酸水溶液の2=1混合溶液60cc (pH2以
下)に加え、40℃に加温しながら攪はん溶解する。温
度を一定に保ちながら、10%水酸化ナトリウム水溶液
をゆっくり滴下し、pH6,5まで中和する。析出した
結晶をろ過、乾燥し白色板状結晶9.5gを得た。
Example 2 10 g of crude crystals of N-lauroyl lysine were mixed with methanol and 1
Add to 60 cc of a 2=1 mixed solution of 0% aqueous hydrochloric acid (pH 2 or less) and stir to dissolve while heating to 40°C. While keeping the temperature constant, slowly drop a 10% aqueous sodium hydroxide solution to neutralize to pH 6.5. The precipitated crystals were filtered and dried to obtain 9.5 g of white plate-like crystals.

実施例3 10gのグルタミン酸−ω−ラウリルアミドの粗結晶を
イソプロパツールと15%水酸化ナトリウム水溶液の3
:1混合溶液60cc (pH12以上)に加え、40
°Cに加温しながら攪はん溶解する。温度を一定に保ち
ながら、10%塩酸水溶液をゆっくり滴下し、pH6,
5まで中和する。
Example 3 10 g of crude crystals of glutamic acid-ω-laurylamide were mixed with isopropanol and 15% aqueous sodium hydroxide solution.
:1 Add to 60cc of mixed solution (pH 12 or higher) and add 40cc of mixed solution
Stir and dissolve while heating to °C. While keeping the temperature constant, 10% hydrochloric acid aqueous solution was slowly added dropwise to pH 6,
Neutralize up to 5.

析出した結晶をろ過、乾燥し白色板状結晶9,4gを得
た。
The precipitated crystals were filtered and dried to obtain 9.4 g of white plate-like crystals.

実施例4 10gのα−アミノパルミチン酸の粗結晶をメタノール
と10%水酸化ナトリウム水溶液の3:1混合溶液60
cc (pH12以上)に加え、60°Cに加温しなか
ら攪はん溶解する。温度を一定に保ちながら、10%塩
酸水溶液をゆっくり滴下し、pH6,5まで中和する。
Example 4 10 g of crude crystals of α-aminopalmitic acid were dissolved in a 3:1 mixed solution of methanol and 10% aqueous sodium hydroxide solution (60 g).
cc (pH 12 or higher) and stir to dissolve while heating to 60°C. While keeping the temperature constant, slowly drop a 10% aqueous hydrochloric acid solution to neutralize to pH 6.5.

析出した結晶をろ過、乾燥し白色板状結晶9.7gを得
た。
The precipitated crystals were filtered and dried to obtain 9.7 g of white plate-like crystals.

実施例5 10gのN−バルミトイルリジンの粗結晶をメタノール
と10%水酸化カリウム水溶液の3=1混合溶液60c
c (PH12以上)に加え、60℃に加温しなから攪
はん溶解する。温度を一定に保ちながら、10%塩酸水
溶液をゆっくり滴下し、pH6,5まで中和する。析出
した結晶をろ過、乾燥し白色板状結晶9.5gを得た。
Example 5 10 g of crude crystals of N-valmitoyllysine was added to 60 c of a 3=1 mixed solution of methanol and 10% aqueous potassium hydroxide solution.
c (pH 12 or higher) and dissolve by heating to 60°C and stirring. While keeping the temperature constant, slowly drop a 10% aqueous hydrochloric acid solution to neutralize to pH 6.5. The precipitated crystals were filtered and dried to obtain 9.5 g of white plate-like crystals.

比較例I N−ラウロイルリジンの粗結晶10gをメタノールと水
酸化ナトリウムにてpH10,5に調整した水溶液の2
=1混合溶液60cc (pH約10)に加え、加温し
なから攪はん溶解させようと試みた。しかしながら、9
0℃まで加熱しても結晶はほとんど溶解せず、白色板状
結晶を得ることはできなかった。
Comparative Example I 2 of an aqueous solution prepared by adjusting 10 g of crude crystals of N-lauroyl lysine to pH 10.5 with methanol and sodium hydroxide.
An attempt was made to add the mixture to 60 cc of the =1 mixed solution (pH approximately 10) and stir it to dissolve it without heating. However, 9
Even when heated to 0° C., the crystals hardly dissolved and white plate-like crystals could not be obtained.

比較例2 N−ラウロイルリジンの粗結晶10gをメタノールと水
の2=1混合溶液60cc (pH約6゜5)に加え、
加温しなから攪はん溶解させようと試みた。しかしなが
ら、90℃まで加熱しても結晶はほとんど溶解せず、白
色板状結晶を得ることはできなかった。
Comparative Example 2 10 g of crude crystals of N-lauroyl lysine were added to 60 cc of a 2=1 mixed solution of methanol and water (pH about 6°5),
I tried to dissolve it by stirring without heating it. However, even when heated to 90° C., the crystals were hardly dissolved and white plate-like crystals could not be obtained.

比較例3 N−ラウロイルリジンの粗結晶10gをメタノールと塩
酸水溶液の2=1混合溶液60cc (pH約3.0)
に加え、加温しなから攪はん溶解させようと試みた。し
かしながら、90゛Cまで加熱しても結晶はほとんど溶
解せず、白色板状結晶を得ることはできなかった。
Comparative Example 3 10 g of crude crystals of N-lauroyl lysine were added to 60 cc of a 2=1 mixed solution of methanol and aqueous hydrochloric acid (pH approximately 3.0)
In addition, an attempt was made to dissolve the substance by stirring without heating. However, even when heated to 90°C, the crystals hardly dissolved and white plate-like crystals could not be obtained.

比較例4 N−ラウロイルリジンの■結晶10gを40°Cの酢酸
100ccに加え、攪はん溶解させようと試みた。しか
しながら、40℃では結晶はほとんど溶解せず、また、
90℃に加温しても一部溶解しない結晶が残留していた
。不溶物を一過し、冷却晶析して得た結晶は白色針状晶
であった。
Comparative Example 4 10 g of crystals of N-lauroyl lysine were added to 100 cc of acetic acid at 40°C, and an attempt was made to dissolve the mixture by stirring. However, at 40°C, the crystals hardly dissolve, and
Even when heated to 90°C, some undissolved crystals remained. The insoluble matter was passed through and the crystals obtained by cooling and crystallization were white needle-shaped crystals.

発明の効果 本発明の有機板状晶の製造法は、従来難溶性であるため
精製および晶析が困難であったアミノ酸誘導体の工業的
規模での製造に効果を発揮する。
Effects of the Invention The method for producing organic platelet crystals of the present invention is effective in producing on an industrial scale amino acid derivatives, which have conventionally been difficult to purify and crystallize due to their sparse solubility.

具体的にその効果を述べるならば、本発明の条件にて晶
析を行うことにより、従来の方法では得難かった、化粧
品や潤滑剤などの分野で用いるのに好適な、滑沢性に優
れたへき開性を有する板状晶を得ることが可能となる。
Specifically, by performing crystallization under the conditions of the present invention, it is possible to achieve excellent lubricity, which is difficult to obtain with conventional methods and is suitable for use in fields such as cosmetics and lubricants. It becomes possible to obtain plate-like crystals having cleavage properties.

また、結晶析出時の制御がしやすくなり、均一な粒度の
結晶が得られる、脱色精製効率が高まる、さらには発泡
が抑制される結果、単位晶析槽容量当りの結晶収り上げ
旦が増大するなどの工業的利点が挙げられる。
In addition, it becomes easier to control the crystal precipitation process, yielding crystals with uniform particle size, increasing decolorization purification efficiency, and suppressing foaming, which increases the number of crystals collected per unit crystallization tank capacity. Industrial advantages include:

Claims (1)

【特許請求の範囲】 1、下記一般式(1)〜(3)で表されるN−長鎖モノ
アシル塩基性アミノ酸、酸性アミノ酸−ω−長鎖アミド
、α−アミノ長鎖脂肪酸などのアミノ酸誘導体をpH2
以下またはpH11以上の水性溶媒に溶解させた後中和
し、晶析することを特徴とする有機板状晶の製造法。 ▲数式、化学式、表等があります▼(1) ▲数式、化学式、表等があります▼(2) (ただし、R1およびR2は炭素数7〜21の長鎖アル
キル基を、R3は炭素数8〜20の長鎖アルキル基を表
す、また、mおよびnは1〜4の整数を表す。) 2、水性溶媒がメタノール、エタノール、プロパノール
、イソプロパノール、イソブタノール、ブタノール等の
低級アルコール類、エチレングリコール、グリセリン、
1,3ブチレングリコール等の多価アルコール類、アセ
トン、メチルエチルケトン等の低級ケトン類等の親水性
有機溶媒のうち少なくとも一種を95〜5vol.%の
範囲で含有する水溶液からなる請求項(1)記載の有機
板状晶の製造方法。
[Scope of Claims] 1. Amino acid derivatives such as N-long-chain monoacyl basic amino acids, acidic amino acids-ω-long-chain amides, and α-amino long-chain fatty acids represented by the following general formulas (1) to (3) pH2
1. A method for producing organic platelet crystals, which comprises dissolving them in an aqueous solvent having a pH of 11 or less, followed by neutralization and crystallization. ▲There are mathematical formulas, chemical formulas, tables, etc.▼(1) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(2) (However, R1 and R2 are long-chain alkyl groups with 7 to 21 carbon atoms, and R3 is a long-chain alkyl group with 8 carbon atoms. ~20 represents a long chain alkyl group, and m and n represent integers of 1 to 4.) 2. The aqueous solvent is lower alcohols such as methanol, ethanol, propanol, isopropanol, isobutanol, butanol, ethylene glycol , glycerin,
95 to 5 vol. of at least one hydrophilic organic solvent such as polyhydric alcohols such as 1,3 butylene glycol, and lower ketones such as acetone and methyl ethyl ketone. The method for producing organic platelet crystals according to claim 1, which comprises an aqueous solution containing in the range of %.
JP6796788A 1988-03-22 1988-03-22 Production of organic plate crystal Granted JPH01242563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6796788A JPH01242563A (en) 1988-03-22 1988-03-22 Production of organic plate crystal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6796788A JPH01242563A (en) 1988-03-22 1988-03-22 Production of organic plate crystal

Publications (2)

Publication Number Publication Date
JPH01242563A true JPH01242563A (en) 1989-09-27
JPH0325413B2 JPH0325413B2 (en) 1991-04-05

Family

ID=13360253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6796788A Granted JPH01242563A (en) 1988-03-22 1988-03-22 Production of organic plate crystal

Country Status (1)

Country Link
JP (1) JPH01242563A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014317A1 (en) * 1999-08-19 2001-03-01 Ajinomoto Co., Inc. Nε-LONG CHAIN ACYLLYSINE CRYSTALS, PROCESS FOR PRODUCING THE SAME AND COSMETICS CONTAINING THE SAME
WO2011088327A2 (en) 2010-01-15 2011-07-21 Ajinomoto Co., Inc. N-acyl basic amino acid dispersion
WO2020262367A1 (en) * 2019-06-27 2020-12-30 味の素株式会社 Nε-LONG CHAIN ACYLIDINE CRYSTAL PRODUCTION METHOD AND COMPOSITION CONTAINING SAID CRYSTALS

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014317A1 (en) * 1999-08-19 2001-03-01 Ajinomoto Co., Inc. Nε-LONG CHAIN ACYLLYSINE CRYSTALS, PROCESS FOR PRODUCING THE SAME AND COSMETICS CONTAINING THE SAME
US6555708B1 (en) * 1999-08-19 2003-04-29 Ajinomoto Co., Inc. N-ε-long chain acyllsine crystals, process for producing the same and cosmetics containing the same
JP4826049B2 (en) * 1999-08-19 2011-11-30 味の素株式会社 Nε-long chain acyl lysine crystal, method for producing the same, and cosmetics containing the same
WO2011088327A2 (en) 2010-01-15 2011-07-21 Ajinomoto Co., Inc. N-acyl basic amino acid dispersion
WO2011088327A3 (en) * 2010-01-15 2012-05-10 Ajinomoto Co., Inc. N-acyl basic amino acid dispersion
JP2013517289A (en) * 2010-01-15 2013-05-16 味の素株式会社 N-acyl basic amino acid dispersion
US9034924B2 (en) 2010-01-15 2015-05-19 Ajinomoto Co., Ltd. N-acyl basic amino acid dispersion
WO2020262367A1 (en) * 2019-06-27 2020-12-30 味の素株式会社 Nε-LONG CHAIN ACYLIDINE CRYSTAL PRODUCTION METHOD AND COMPOSITION CONTAINING SAID CRYSTALS
JPWO2020262367A1 (en) * 2019-06-27 2020-12-30
US12221403B2 (en) 2019-06-27 2025-02-11 Ajinomoto Co., Inc. Nε-long chain acyl lysine crystal production method and composition containing said crystals
JP2025071320A (en) * 2019-06-27 2025-05-02 味の素株式会社 Method for producing Nε-long chain acyl lysine crystals and composition containing the crystals

Also Published As

Publication number Publication date
JPH0325413B2 (en) 1991-04-05

Similar Documents

Publication Publication Date Title
JP5305248B2 (en) New nateglinide crystals
JPS58192890A (en) Novel alkyloxime derivative of 7-aminothiazolylacetamidocephalosporanic acid, manufacture and medicinal composition
PT94188B (en) PROCESS FOR THE PURIFICATION OF AMINOMETHYLENOPHOSPHONIC ACIDS
CN114072378A (en) Method for preparing metastable crystal modification of N-(aminoiminomethyl)-2-aminoacetic acid (III)
WO2000053576A1 (en) Gelling or coagulating agents for liquid organic media
LU86540A1 (en) CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS
BR0114728B1 (en) Method for producing an acylphenylalanine
JPH0325413B2 (en)
JP5460209B2 (en) Method for purifying 4-amino-5-chloro-2-ethoxy-N-[[4- (4-fluorobenzyl) -2-morpholinyl] methyl] benzamide
JP7012725B2 (en) Improved synthesis of lysine glycine acetylsalicylate particles
EP1028106B1 (en) Process for the preparation of guanidine derivatives
JP2971291B2 (en) Production method of optically active 2-aminobutyric acid
JP2940044B2 (en) Method for producing mixed crystals of 5&#39;-disodium guanylate / 5&#39;-disodium inosinate
US4551548A (en) Process for the recovery of S-(carboxymethyl)-(R)-cysteine and S-(carboxymethyl)-(S)-cysteine
JP2007238596A (en) Direct process for forming amino acid dihydrochloride
JP3080801B2 (en) Taurine purification method
US2867661A (en) Non-hygroscopic antibiotic salt
JP2003096039A (en) Method for producing high-purity N-long-chain acylamino acid salt
RU2849774C2 (en) Metastable crystal modification and method for obtaining it
CN1896068B (en) A kind of method for preparing xyltriazinone
JP3326700B2 (en) Method for producing amide group-containing guanidine derivative or salt thereof
JP3541440B2 (en) Crystallization method of L-cystine and novel crystal
JPH01190661A (en) Purification of 4,4&#39;-dihydroxydiphenylsulfone
US850111A (en) Bromin derivative of fatty acids.
BR112021026604B1 (en) PROCESS FOR PREPARING N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID CONTAINING N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID IN A THERMODYNAMICALLY METASTABLE CRYSTALLINE MODIFICATION.

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term